The association of sequence variants in DNA repair and cell cycle genes with cancers of the upper aerodigestive tract

Carcinogenesis

Volumn 28, Issue 3, 2007, Pages 665-671

  Hall, Janet ^a,j   Hashibe, Mia ^a   Boffetta, Paolo ^a   Gaborieau, Valerie ^a   Moullan, Norman ^a   Chabrier, Amelie ^a   Zaridze, David ^b   Shangina, Oxana ^b   Szeszenia Dabrowska, Neonila ^c   Mates, Dana ^d   Janout, Vladimir ^e   Fabiánová, Eleonóra ^f   Holcatova, Ivana ^g   Hung, Rayjean J ^a,h   McKay, James ^a   Canzian, Federico ^a,i   Brennan, Paul ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

^b N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^c NOFER INSTITUTE OF OCCUPATIONAL MEDICINE   (Poland)

^d Institute of Hygiene Public Health Health Services and Management   (Romania)

^e PALACKÝ UNIVERSITY   (Czech Republic)

^f Specialized State Health Institute   (Slovakia)

^g CHARLES UNIVERSITY   (Czech Republic)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^j INSTITUT CURIE   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHECKPOINT KINASE 2; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

ADULT; AGED; ALLELE; ARTICLE; CANCER RISK; CANCER SUSCEPTIBILITY; CELL CYCLE REGULATION; CONTROLLED STUDY; CZECH REPUBLIC; DIGESTIVE SYSTEM CANCER; DNA DAMAGE; DNA DETERMINATION; DNA REPAIR; DNA SEQUENCE; ESOPHAGUS CANCER; FEMALE; GENETIC ASSOCIATION; GENETIC CODE; GENETIC RISK; GENETIC VARIABILITY; HETEROZYGOTE; HOMOZYGOSITY; HUMAN; INTRON; LARYNX CANCER; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NUCLEOTIDE SEQUENCE; PHARYNX CANCER; POLAND; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; RISK ASSESSMENT; RISK FACTOR; ROMANIA; RUSSIAN FEDERATION; SINGLE NUCLEOTIDE POLYMORPHISM; SLOVAKIA; SQUAMOUS CELL CARCINOMA; UPPER GASTROINTESTINAL TRACT;

EID: 34047126918     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgl160     Document Type: Article

References (34)

1. IARC Working Group (1988) Alcohol drinking. IARC Monogr. Eval. Carcinog. Risks Hum., 44, 1-378.
2. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans (2004) Tobacco smoke and involuntary smoking. IARC Monogr. Eval. Carcinog. Risks Hum., 83, 1-1438.
3. Cheng,L., Eicher,S.A., Guo,Z., Hong,W.K., Spitz,M.R. and Wei,Q. (1998) Reduced DNA repair capacity in head and neck cancer patients. Cancer Epidemiol. Biomarkers Prev., 7, 465-468.
4. Hu,J.J., Mohrenweiser,H.W., Bell,D.A., Leadon,S.A. and Miller,M.S. (2002) Symposium overview: Genetic polymorphisms in DNA repair and cancer risk. Toxicol. Appl. Pharmacol., 185, 64-73.
5. Spitz,M.R., Fueger,J.J., Beddingfield,N.A., Annegers,J.F., Hsu,T.C., Newell,G.R. and Schantz,S.P. (1989) Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49, 4626-4628.
6. Hung,R.J., Hel,O., Tavtigian,S.V., Brennan,P., Boffetta,P. and Hashibe,M. (2005) Perspectives on the molecular epidemiology of aerodigestive tract cancers. Mutat. Res., 592, 102-118.
7. Bartek,J. and Lukas,J. (2003) Chk1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell, 3, 421-429.
8. Gemignani,F., Landi,S., Vivant,F., Zienolddiny,S., Brennan,P. and Canzian,F. (2002) A catalogue of polymorphisms related to xenobiotic metabolism and cancer susceptibility. Pharmacogenetics, 12, 459-463.
9. Hashibe,M., Boffetta,P., Zaridze,D., Shangina,O., Szeszenia-Dabrowska,N., Mates,D., Janout,V., Fabianova,E., Bencko,V., Moullan,N. et al. (2006) Evidence for an important role of alcohol- and aldehyde-metabolizing genes in cancers of the upper aerodigestive tract. Cancer Epidemiol. Biomarkers Prev., 15, 696-703.
10. Scelo,G., Constantinescu,V., Csiki,I., Zaridze,D., Szeszenia-Dabrowska,N., Rudnai,P., Lissowska,J., Fabianova,E., Cassidy,.A., Slamova,A. et al. (2004) Occupational exposure to vinyl chloride, acrylonitrile and styrene and lung cancer risk (Europe). Cancer Causes Control, 15, 445-452.
11. Mannetje,A., Fevotte,J., Fletcher,T., Brennan,P., Legoza,J., Szeremi,M., Paldy,A., Brzeznicki,S., Gromiec,J., Ruxanda-Artenie,C. et al. (2003) Assessing exposure misclassification by expert assessment in multicenter occupational studies. Epidemiology, 14, 585-592.
12. Hung,R.J., Brennan,P., Canzian,F., Szeszenia-Dabrowska,N., Zaridze,D., Lissowska,J., Rudnai,P., Fabianova,E., Mates,D., Foretova,L. et al. (2005) Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study. J. Natl. Cancer Inst., 97, 567-576.
13. Morin,P.A., Saiz,R. and Monjazeb,A. (1999) High-throughput single nucleotide polymorphism genotyping by fluorescent 5′ exonuclease assay. Biotechniques, 27, 538-540.
14. Myakishev,M.V., Khripin,Y., Hu,S. and Hamer,D.H. (2001) High-throughput SNP genotyping by allele-specific PCR with universal energy-transfer-labeled primers. Genome Res., 11, 163-169.
15. Belousov,Y.S., Welch,R.A., Sanders,S., Mills,A., Kulchenko,A., Dempcy,R., Afonina,I.A., Walburger,D.K., Glaser,C.L., Yadavalli,S. et al. (2004) Single nucleotide polymorphism genotyping by two colour melting curve analysis using the MGB Eclipse Probe System in challenging sequence environment. Hum. Genomics, 1, 209-217.
16. Wacholder,S., Chanock,S., Garcia-Closas,M., El Ghormli,L. and Rothman,N. (2004) Assessing the probability that a positive report is false: An approach for molecular epidemiology studies. J. Natl. Cancer Inst., 96, 434-442.
17. Ma,S., Egyhazi,S., Ueno,T., Lindholm,C., Kreklau,E.L., Stierner,U., Ringborg,U. and Hansson,J. (2003) O6-methylguanine-DNA-methyltransferase expression and gene polymorphisms in relation to chemotherapeutic response in metastatic melanoma. Br. J. Cancer, 89, 1517-1523.
18. Huang,W.Y., Olshan,A.F., Schwartz,S.M., Berndt,S.I., Chen,C., Llaca,V., Chanock,S.J., Fraumeni,J.F.,Jr and Hayes,R.B. (2005) Selected genetic polymorphisms in MGMT, XRCC1, XPD, and XRCC3 and risk of head and neck cancer: A pooled analysis. Cancer Epidemiol. Biomarkers Prev., 14, 1747-1753.
19. Hill,C.E., Wickliffe,J.K., Wolfe,K.J., Kinslow,C.J., Lopez,M.S. and Abdel-Rahman,S.Z. (2005) The L84F and the I143V polymorphisms in the O6-methylguanine-DNA-methyltransferase (MGMT) gene increase human sensitivity to the genotoxic effects of the tobacco-specific nitrosamine carcinogen NNK. Pharmacogenet. Genomics, 15, 571-578.
20. Hung,R.J., Hall,J., Brennan,P. and Boffetta,P. (2005) Genetic polymorphisms in the base excision repair pathway and cancer risk: A HuGE review. Am. J. Epidemiol., 162, 925-942.
21. Elahi,A., Zheng,Z., Park,J., Eyring,K., McCaffrey,T. and Lazarus,P. (2002) The human OGG1 DNA repair enzyme and its association with orolaryngeal cancer risk. Carcinogenesis, 23, 1229-1234.
22. Zhang,Z., Shi,Q., Wang,L.E., Sturgis,E.M., Spitz,M.R., El Naggar,A.K., Hong,W.K. and Wei,Q. (2004) No association between hOGG1 Ser326Cys polymorphism and risk of squamous cell carcinoma of the head and neck. Cancer Epidemiol. Biomarkers Prev., 13, 1081-1083.
23. Hill,J.W. and Evans,M.K. (2006) Dimerization and opposite base-dependent catalytic impairment of polymorphic S326C OGG1 glycosylase. Nucleic Acids Res., 34, 1620-1632.
24. Zienolddiny,S., Campa,D., Lind,H., Ryberg,D., Skaug,V., Stangeland,L., Phillips,D.H., Canzian,F. and Haugen,A. (2006) Polymorphisms of DNA repair genes and risk of non-small cell lung cancer. Carcinogenesis, 27, 560-567.
25. Wu,X., Zhao,H., Wei,Q., Amos,C.I., Zhang,K., Guo,Z., Qiao,Y., Hong,W.K. and Spitz,M.R. (2003) XPA polymorphism associated with reduced lung cancer risk and a modulating effect on nucleotide excision repair capacity. Carcinogenesis, 24, 505-509.
26. Park,J.Y., Park,S.H., Choi,J.E., Lee,S.Y., Jeon,H.S., Cha,S.I., Kim,C.H., Park,J.H., Kam,S., Park,R.W. et al. (2002) Polymorphisms of the DNA repair gene xeroderma pigmentosum group A and risk of primary lung cancer. Cancer Epidemiol. Biomarkers Prev., 11, 993-997.
27. Butkiewicz,D., Popanda,O., Risch,A., Edler,L., Dienemann,H., Schulz,V., Kayser,K., Drings,P., Bartsch,H. and Schmezer,P. (2004) Association between the risk for lung adenocarcinoma and a (-4) G-to-A polymorphism in the XPA gene. Cancer Epidemiol. Biomarkers Prev., 13, 2242-2246.
28. Pietsch,E.C., Humbey,O. and Murphy,M.E. (2006) Polymorphisms in the p53 pathway. Oncogene, 25, 1602-1611.
29. Gemignani,F., Moreno,V., Landi,S., Moullan,N., Chabrier,A., Gutierrez-Enriquez,S., Hall,J., Guino,E., Peinado,M.A., Capella,G. et al. (2004) A TP53 polymorphism is associated with increased risk of colorectal cancer and with reduced levels of TP53 mRNA. Oncogene, 23, 1954-1956.
30. Bond,G.L., Hu,W. and Levine,A. (2005) A single nucleotide polymorphism in the MDM2 gene: From a molecular and cellular explanation to clinical effect. Cancer Res., 65, 5481-5484.
31. Ahn,J., Urist,M. and Prives,C. (2004) The Chk2 protein kinase. DNA Repair, 3, 1039-1047.
32. Cybulski,C., Gorski,B., Huzarski,T., Masojc,B., Mierzejewski,M., Debniak,T., Teodorczyk,U., Byrski,T., Gronwald,J., Matyjasik,J. et al. (2004) CHEK2 is a multiorgan cancer susceptibility gene. Am. J. Hum. Genet., 75, 1131-1135.
33. Benhamou,S., Tuimala,J., Bouchardy,C., Dayer,P., Sarasin,A. and Hirvonen,A. (2004) DNA repair gene XRCC2 and XRCC3 polymorphisms and susceptibility to cancers of the upper aerodigestive tract. Int. J. Cancer, 112, 901-904.
34. Shen,H., Sturgis,E.M., Dahlstrom,K.R., Zheng,Y., Spitz,M.R. and Wei,Q. (2002) A variant of the DNA repair gene XRCC3 and risk of squamous cell carcinoma of the head and neck: A case-control analysis. Int. J. Cancer, 99, 869-872.